Congratulations to the our affiliates who made the Pathologist Power List 2020!

Congratulations to Drs. Greg Tsongalis, Karen Kaul, and Jeff Mederios who were all recently featured in The Pathologist Power List.

Dr. Tsongalis recently became Vice Chair of Research in the Department of Pathology and Laboratory Medicine at Dartmouth-Hitchcock Medical Center and the Geisel School of Medicine at Dartmouth and is active in COVID-19 research. He is a Past President of the Association for Molecular Pathology and was awarded the Jeffrey A. Kant Leadership Award in 2018. He also received the ASIP Robbins Distinguished Educator Award in 2019, and is a member of the ASIP Committee for Career Development and Diversity and Nominating Committee.

Gregory J. Tsongalis

Part of the Power List 2020 You nominated and our expert judging panels deliberated – and now, we proudly showcase this diversity of talent in The Pathologist’s 2020 Power List. Go to The Power List 2020

Karen L. Kaul

Part of the Power List 2020 You nominated and our expert judging panels deliberated – and now, we proudly showcase this diversity of talent in The Pathologist’s 2020 Power List. Go to The Power List 2020

Karen Kaul was the first female Senior Associate Editor of the Journal of Molecular Diagnostics and then she became the Editor-In-Chief for ten years (2000-2010), and remains on the Editorial Board. She was awarded the Jeffrey A. Kant Leadership Award in 2008 from the Association for Molecular Pathology.

L. Jeffrey Medeiros

Part of the Power List 2020 You nominated and our expert judging panels deliberated – and now, we proudly showcase this diversity of talent in The Pathologist’s 2020 Power List. Go to The Power List 2020

See the full list below:

The Power List 2020

From motivating mentors to trailblazing innovators, social media gurus to laboratory medicine heroes, it is the inspirational individuals who make laboratory medicine such a fantastic field. You nominated and our expert judging panels deliberated – and now, we proudly showcase this diversity of talent in The Pathologist’s 2020 Power List.

Sharing large-scale patient data to understand COVID-19 severity

HCS and ASIP member Dr. Alejandro Adam recently co-authored two preprints with collaborators at Albany Medical College, the University of Wisconsin, Madison and the Morgridge Institute for Research. This research, led by Drs. Ariel Jaitovich (Albany Med) and Joshua Coon (UW-Madison), shows how multiplexed measurements, large-scale multi-omics analysis and artificial intelligence can shed light into why some patients quickly recover, while others have a much worse prognosis. The data shows high levels of CCL19, but low levels of PDGF-AA, dysregulation of platelet function, blood coagulation, acute phase response, and endotheliopathy in patients with worse prognosis, providing insight into novel potential therapeutic interventions. All cytokine profiling, metabolomics, lipidomics, proteomics, transcriptomics from a prospective cohort of 120 patients were made freely available to the whole scientific community.

More info:

  • ASIP Member Dr. James Musser featured for COVID-19 Research

    James Musser, MD, spoke with The New York Times about how COVID-19’s genetic code plays a vital role in controlling the virus.

    Since last March, a team of researchers led by Dr. James Musser, chair of the department of pathology and genomic medicine at Houston Methodist Hospital, have been sequencing the viral genomes drawn from patients — 20,000 genomes so far. This new study has found that every coronavirus variant of concern to researchers around the world has been circulating in Houston at a low level for at least six to eight weeks. Houston is the first U.S. city to find all of the variants, including those recently reported in California and New York and the ones found in Brazil, Britain and South Africa.

  • #PISA2020 Day 5
    Program Yesterday was another full day of science, mentoring, and networking at PISA 2020. With Day 4 of the meeting in the books, we find ourselves at Day 5 – the final day of PISA 2020. TODAY at PISA 2020, we begin with Trainee Advising Sessions at 8:00 AM and 9:00 AM on the topics […]
  • Pathologists Fighting COVID-19 – Sally Davis
    K-State Assistant Professor of Experimental Pathology, Dr. A. Sally Davis, an ASIP member and HCS Councilor, will lead USDA-National Institute of Food and Agriculture Rapid Response project “Translating SARS-CoV-2 Research Into Practical Solutions For The Meat And Poultry Processing Industry” to find scientific solutions to protect meat and poultry plant workers and their surrounding communities […]

Washington & Jefferson College to Honor ASIP Member Dr. Mark L. Tykocinski During Commencement Ceremony

Dr. Tykocinski is past president of the American Society for Investigative Pathology (ASIP) and the Association of Pathology Chairs. He has been on the editorial boards of the American Journal of Pathology, Molecular Oncology and Genetics Research, and was honored with the Warner-Lambert/Parke-Davis Award for Outstanding Research from ASIP. Recently, Tykocinski has received prestigious lifetime achievement awards from the Philadelphia County Medical Society (2017 Strittmatter Award) and the Philadelphia-Israel Chamber of Commerce (2019), and was recognized with a Distinguished Alumnus Award from NYU School of Medicine.

Read More

Dr. Martin Matzuk named chair of Pathology & Immunology

Dr. Martin Matzuk has been named chair of the Department of Pathology & Immunology at Baylor College of Medicine. He has been serving as interim chair since March 2019.

Matzuk is professor of pathology & immunology, molecular and human genetics, molecular and cellular biology, and pharmacology and chemical biology at Baylor. He also is the director of the Center for Drug Discovery and member of the NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor. He holds the Stuart A. Wallace Chair and Robert L. Moody, Sr. Chair in the Department of Pathology & Immunology.

He received the ASIP Outstanding Investigator Award from the American Society for Investigative Pathology in 2002.

Lab Page

Grab a shovel: How the over 65K published articles on COVID can teach us to be better scientists.

On July 23rd 2020 there were a reported total 66,883 peer reviewed open access articles on the novel coronavirus COVID-19. That does not include the 19,420 preprints that have also been reported. So let’s say we are at over 85K publications about COVID-19 in 2020. I don’t know about you, but that sounds out of control to me! Amongst all the wonderful data that I am sure is out there, we have to reconsider what is actually going on here.

An article published on the site has listed 25 retracted and 3 temporarily retracted articles on COVID-19.

I think this shines a light on a larger problem that is plaguing the scientific community, we are seeing the same thing in politics. It is not enough to be right, you just need to be first. If you read scientific literature you risk being misinformed, but if you don’t read and do your research then you are uninformed. So where do we find ourselves?

I was drawn to a particular article published in Nature Molecular and Cellular Immunology entitled SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion. This paper was accepted in 3 days! 3 days! It was retracted 3 months later because the investigators used a T-cell line instead of primary T-cells. What is worse is that this paper was accessed 225 thousand times and cited 38 times between its publication date on April 7, 2020 and its retraction date on July 10, 2020.

Now during a pandemic such as this we need to get information out as quickly as we get it but there has to be some kind of professional courtesy and accountability, especially at this level of publication. Haven’t we already learned our lesson about this with the twists and false reports about how vaccines cause autism? As for the paper mentioned above, it is entirely possible that the mechanism is conserved between the cell line and the primary cells, but we do not get to make that assumption, not now, not ever! As scientists we are responsible for creating the next generation of treatments, the health in the world is in our hands.

Let us learn one more lesson from COVID and remind ourselves that our work is not just about getting tenure or winning a grant, we are the experts in science and medicine and have a professional responsibility to the people. Our work can directly influence treatment plans and the healthcare of the people and we need to consider what we publish and how we publish it. Lets take that extra step and make sure we keep a high standard of scientific rigor and responsibility.

Interested in contributing original content to the ASIP blog? Contact me at to get involved!


The ASIP is hosting another free virtual hangout for trainee and junior members July 30th at 6P.M. EST. We will be discussing writing training grants during COVID and maximizing your ability to get funding. If you are interested please register by clicking the link below:


PISA 2020 is going virtual! Stay tuned for updates on PISA 2020 at

Interested in becoming a member of ASIP? Contact me at